sorafenib
NDC 24979-715, sorafenib, tablet, film coated, from Upsher-Smith Laboratories, LLC.
- Product NDC
- 24979-715
- Status
- Listed
- Labeler
- Upsher-Smith Laboratories, LLC
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209050
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/24979-715 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SORAFENIB200 mg/1
Pharmacologic classes
Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 24979-715-04 | 24979071504 | 60 TABLET, FILM COATED in 1 BOTTLE (24979-715-04) |
| 24979-715-44 | 24979071544 | 120 TABLET, FILM COATED in 1 BOTTLE (24979-715-44) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/68aa4b7f-3f13-4e73-b572-aa6c11a8429c
Use it
Look up 24979-715 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/24979-715 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 24979-715. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.